Hillstar Bio | $67,000,000 | (Apr 2, 2025)
Sympera AI | $10,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
Certified by Founder
Lodge
HEPHAISTOS-Pharma
start up
France
- Orsay, Île-de-France
- 17/05/2024
- Seed
- $11,189,199
HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.
- Industry Biotechnology
- Website https://hephaistos-pharma.fr/
- LinkedIn https://www.linkedin.com/company/hephaistos-pharma/
Related People
Frederic CAROFFFounder
France -
Boulogne-Billancourt, Île-de-France
Biotechnology entrepreneur for 10 years, I am currently the CEO of HEPHAISTOS-Pharma, a biotech company developing new immunotherapies in oncology in order to revolutionize the effectiveness of cancer treatments.
Our ONCO-Boost technology allows us to stimulate patients' immunity to treat cold tumors such as Osteosarcoma, an orphan disease, but also to increase the effectiveness of therapeutic antibodies in combination.
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
InfiniLink | $10,000,000 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)
EVident Battery, Inc. | $3,200,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Atomic(US) | $10,000,000 | (Apr 2, 2025)
ControlTheory | $5,000,000 | (Apr 2, 2025)